Bone Marrow Harvest from Mouse Hind Limb
JoVE Encyclopedia of Experiments
Cancer Research
0 views • 3:38 min • February 9th, 2026
Loading...
Overview
This article presents a detailed protocol for isolating fresh whole bone marrow from the hind limbs of mice, specifically for downstream mass cytometry analysis of neutrophil-lineage cells. The method is designed to facilitate the investigation of bone marrow defects relevant to blood disorders such as leukemia.
Key Study Components
Area of Science
- Hematology
- Immunology
- Cell Biology
Background
- Bone marrow is a critical tissue containing hematopoietic stem cells responsible for blood cell production.
- Isolation of bone marrow from large bones like the femur and tibia yields high cell numbers.
- Analyzing bone marrow is essential for studying immune cell populations and blood disorders.
- Mass cytometry enables high-dimensional analysis of cell populations, including neutrophil-lineage cells.
Purpose of Study
- To provide a reproducible protocol for harvesting whole bone marrow from mouse hind limbs.
- To enable mass cytometry analysis of neutrophil-lineage cells from freshly isolated bone marrow.
- To support research into bone marrow defects associated with blood disorders.
Methods Used
- Euthanization of 6–10 week old C57 black-6 mice.
- Sterilization of the surgical area with 70% ethanol.
- Dissection to expose and isolate the tibia and femur from hind limbs.
- Removal of muscle tissue to access bones.
- Placement of bones in cold PBS to preserve cell viability.
- Preparation of a double-layered microcentrifuge tube system with a hole punched in the inner tube.
- Centrifugation to extract bone marrow into the collection tube.
Main Results
- Efficient isolation of whole bone marrow from mouse femur and tibia.
- Harvested bone marrow is suitable for downstream applications such as mass cytometry.
- The protocol maintains physiological conditions to preserve cell integrity.
- Yields sufficient cell numbers for analysis of neutrophil-lineage and other hematopoietic cells.
Conclusions
- This protocol provides a reliable method for isolating whole bone marrow from mouse hind limbs.
- The approach supports high-quality sample preparation for mass cytometry and related analyses.
- It is applicable for studies investigating hematopoietic and immune cell populations in health and disease.
Frequently Asked Questions
What mouse strain and age are recommended for this protocol?
The protocol uses 6–10 week old C57 black-6 mice, which are commonly employed in immunological and hematological studies.
Why are the femur and tibia chosen for bone marrow isolation?
These large bones provide a high yield of bone marrow cells, making them ideal for downstream analyses such as mass cytometry.
How is sterility maintained during the procedure?
The surgical area and mouse are sterilized with 70% ethanol, and the procedure is performed on a sterile surgical pad using sterile instruments.
What is the purpose of using cold PBS during bone isolation?
Cold PBS helps maintain physiological conditions and preserves cell viability during the isolation process.
How is bone marrow extracted from the bones?
Bones are placed in a microcentrifuge tube with a hole at the bottom, nested inside a larger tube, and centrifuged to force the marrow out for collection.
What downstream applications is the isolated bone marrow suitable for?
The harvested bone marrow is suitable for mass cytometry and other analyses of hematopoietic and immune cell populations.
Can this protocol be adapted for other mouse strains or ages?
While optimized for C57 black-6 mice aged 6–10 weeks, the protocol may be adapted for other strains or ages with appropriate adjustments.
Executive Industry Relevance
Efficient isolation of whole bone marrow from mouse hind limbs enables high-yield acquisition of hematopoietic and immune cell populations for discovery-stage research. This protocol supports robust target validation and mechanistic de-risking in hematology and immunology pipelines, particularly for blood disorder models. Reliable sample preparation underpins predictive confidence in downstream mass cytometry and translational studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of hematopoietic pathways and immune cell lineage specification.
- Supports functional target validation in disease-relevant bone marrow systems.
- Facilitates mechanistic de-risking for blood disorder research portfolios.
Screening & Assay Development
- Provides standardized, high-yield cell preparations for quantitative mass cytometry assays.
- Ensures reproducibility and scalability for screening immune cell populations.
- Enables reliable evaluation of compound effects on hematopoietic cells.
Translational & Preclinical Research
- Aligns with disease-relevant models for preclinical investigation of blood disorders.
- Maintains continuity from discovery through translational biomarker analysis.
- Supports risk-adjusted advancement of hematology and immunology assets.
Pipeline & Workflow Integration
This bone marrow harvest protocol integrates at the interface of early discovery and preclinical research, providing foundational material for lead identification and translational studies.
- Discovery Biology: Supplies primary cells for hypothesis testing and pathway analysis in hematopoietic research.
- Screening: Delivers reproducible, quantitative cell inputs for high-dimensional cytometry assays.
- Analytics: Enables robust measurement of immune cell populations and comparative condition analysis.
- Translational Research: Bridges discovery findings to preclinical disease models and biomarker studies.
- Enterprise Reuse: Establishes a standardized protocol adaptable across hematology and immunology programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune cell studies.
- Operational Value: Promotes standardization, reproducibility, and scalability in sample preparation.
- Strategic Value: Improves go/no-go decision quality and capital efficiency in early-stage portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of hematology and immunology assets.
Implementation Considerations
- Requires expertise in mouse dissection and sterile technique.
- Needs access to microcentrifuges and mass cytometry infrastructure.
- Demands cross-team standardization for reproducible sample quality.
- Adaptable to other mouse strains or ages with protocol adjustments.
- Cell viability and yield depend on precise handling and cold PBS use.
Biopharma FAQs
Why is null hypothesis testing critical for bone marrow defect validation?
Null hypothesis testing enables objective assessment of whether observed differences in bone marrow cell populations are statistically significant, supporting rigorous target validation in hematology research.
How does independent variable isolation in mouse bone harvest fit the discovery pipeline?
Isolating variables such as mouse strain, age, and bone source ensures that downstream analyses reflect true biological effects, strengthening mechanistic insights in early discovery workflows.
What do quantitative dependent variable measurements from mass cytometry enable?
Quantitative mass cytometry readouts allow precise characterization of immune and hematopoietic cell populations, enabling robust comparison across experimental conditions and supporting data-driven decisions.
Why do replication requirements in bone marrow harvest matter for cross-functional teams?
Replication ensures that cell yields and population profiles are consistent, facilitating reliable data sharing and collaboration between discovery, screening, and translational research teams.
What statistical analysis capabilities are needed before implementing mass cytometry outputs?
Teams require statistical tools to analyze cell population distributions, assess significance, and validate reproducibility, ensuring that mass cytometry data inform actionable R&D decisions.
06:17
Osteoclast Derivation from Mouse Bone Marrow
Related Videos
0 Views
08:01
Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Related Videos
0 Views
07:21
Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow
Related Videos
0 Views
10:29
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Related Videos
0 Views
04:00
Isolation and Culture of Bone Marrow Stromal Cells from a Mouse Tibia
Related Videos
0 Views
05:54
Induction of Graft Versus Host Disease in Mouse Models via Allogeneic Bone Marrow and Splenic Cell Transplantation
Related Videos
0 Views
07:10
Femoral Bone Marrow Aspiration in Live Mice
Related Videos
0 Views
11:25
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Related Videos
0 Views
07:17
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Related Videos
0 Views
09:05
Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy
Related Videos
0 Views
Last updated: 1 August 2026